- cafead   May 18, 2020 at 11:32: AM
via Boston biopharmaceutical Moderna announced Monday that “positive” data was collected from an early-stage human trial of a coronavirus vaccine, with all 45 participants producing COVID-19 antibodies—and markets responded positively in pretrading hours, as the possibility of producing a vaccine against the virus moved one small step closer.
article source
article source